期刊文献+

6%羟乙基淀粉(130/0.4)对急性心肌梗死合并休克患者血液流变学的影响 被引量:3

Effect of 6% hydroxyethylstarch(130 / 0.4) on hemorheology in patients with acute myocardial infarction complicated by shock
下载PDF
导出
摘要 目的:观察6%羟乙基淀粉(130/0.4)对急性心肌梗死(AMI)合并休克患者早期液体复苏前后血液流变学的影响。方法:将72例AMI合并休克患者随机分成两组,即Ⅰ组用6%羟乙基淀粉(130/0.4)早期液体复苏;Ⅱ组用平衡盐(1.86%乳酸钠溶液和复方氯化钠溶液之比为1∶2)液体早期复苏,另设36例正常对照组为Ⅲ组。于入科后和液体复苏后2~3 h测定Ⅰ组、Ⅱ组血液流变学指标。结果:Ⅰ组液体复苏后与Ⅱ组液体复苏后相比,全血(高切、低切)黏度、红细胞聚集指数、红细胞压积、纤维蛋白原、血小板聚集率明显降低,差异有统计学意义(P<0.05或P<0.01)。结论:6%羟乙基淀粉(130/0.4)能有效改善AMI合并休克患者血液流变学异常。 Objective To observe the effect of 6% hydroxyethylstarch (130/0.4) on hemorheology inpatients with acute myocardial infarction (AMI) complicated by shock before and after early fluid resuscitation. Methods 72 AMI patients complicated by shock were randomly divided into two groups, namely group with 6% hydroxyethylstarch (130/0.4) for early liquid resuscitation and group Ⅱ with balanced salt (1.86% sodium lactate solution and compound sodium chloride solution for a ratio of 1:2) for liquid recovery; and another 36 subjects was assigned to normal control group (group Ⅲ ). The hemorheological indices were detected after admission and 2 to 3 hours after fluid resuscitation in groups Ⅰ and Ⅱ. Results After fluid resuscitation, high- and low-shear viscosity, red cell aggregation index, hematocrit, fibrinogen, and platelet aggregation rate decreased in group Ⅰ and group Ⅱ , with significant statistical differences (P 〈 0.05 and P 〈 0.01 ). Conclusions 6% hydroxyethylstarch (130/0.4) can effectively improve abnormal hemorheology in patients with AMI complicated by shock.
出处 《实用医学杂志》 CAS 北大核心 2014年第7期1144-1146,共3页 The Journal of Practical Medicine
关键词 心肌梗死 休克 血液流变学 羟乙基淀粉 Myocardial infarction Shock Hemorheology Hydroxyethylstarch
  • 相关文献

参考文献3

二级参考文献40

共引文献27

同被引文献39

  • 1周齐艳.血清对氧磷酶1水平与急性冠脉综合征分型的相关性研究[J].中国全科医学,2013,16(27):3189-3191. 被引量:5
  • 2李文杰,李慧.羟乙基淀粉的不良反应[J].中国药业,2006,15(3):76-77. 被引量:7
  • 3姚桂莲,刘健,王淑翠.羟乙基淀粉致过敏性休克死亡[J].药物不良反应杂志,2006,8(3):213-214. 被引量:7
  • 4周欣,张晓乐.羟乙基淀粉扩容液临床研究进展[J].中国药学杂志,2007,42(9):646-649. 被引量:23
  • 5Glover PA,Rudloff E,Kirby R. Hydroxyethyl starch: A review of pharmacokinetics, pharmacodynamics, current products, and potential clinical risks, benefits, and use[J]. J Vet Emerg Crit Care (San Antonio),2014,26: 10.
  • 6Snygg J,Bech-Hanssen O,L6 nn L,et al. Fluid therapy in acute myocardial infarction: evaluation of predictors of volume re- sponsiveness[J]. Acta Anaesthesiol Scand, 2009, 53(1) :26-33.
  • 7Guerci P, Tran N, Menu P, et al. Impact of fluid resuscitation with hypertonic-hydroxyethyl starch versus lactated ringer on- hemorheology and microcirculation in hemorrhagic shock[J]. Clin Hemorheol Microcirc, 2014, 56(4):301-317.
  • 8McBride D, Hosgood GL, Mansfield CS, et al. Effect of hydroxy- ethyl starch 130/0.4 and 200/0. 5 solutions on canine platelet function in vitro[J]. Am J Vet Res,2013, 74(8) :1133-1137.
  • 9Blong AE, Epstein KL, Brainard BM. In vitro effects of three formulations of hydroxyethyl starch solutions on coagulation and platelet function in horses[J]. Am J Vet Res,2013, 74(5) .. 712-720.
  • 10Da Luz LT, Nascimento B, Shankarakutty AK, et al. Effect of thromboelastography (TEG) and rotational thromboelastom- etry (ROTEM ) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review [J].Crit Care,2014, 18(5) :518.

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部